GlassScriptPhysician profile
Lisa A Dubose
NPI 1861549271
$1,336.65
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $527 · 2022: $355 · 2023: $184 · 2024: $127 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $326.30 | 2021-2023 | Bronchitol |
| Nestle Healthcare Nutrition INC. | $201.26 | 2021-2023 | |
| Philips North America LLC | $184.40 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $87.78 | 2021-2024 | Trikafta |
| Aimmune Therapeutics, INC. | $87.09 | 2024-2025 | Zenpep |
| Astrazeneca Pharmaceuticals LP | $57.62 | 2021-2024 | Fasenra |
| Abbvie INC. | $55.95 | 2021-2024 | |
| Baxter Healthcare | $52.52 | 2023-2025 | Hillrom - Synclara Cough System, Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care |
| Gilead Sciences, INC. | $51.58 | 2021 | |
| Mylan Specialty L.P. | $46.45 | 2021-2023 | Tobi Podhaler |
| Regeneron Healthcare Solutions, INC. | $37.28 | 2023 | Dupixent |
| Covis Pharma Gmbh | $32.06 | 2021 | |
| Genzyme Corporation | $31.42 | 2025 | |
| Alcresta Therapeutics, INC. | $25.00 | 2025 | Relizorb |
| Amgen INC. | $23.34 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.07 | 2021 | |
| Digestive Care, INC. | $13.53 | 2025 | Pertzye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dubose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.